Join our journey
A Norwegian life-science company solving one of the largest medical challenges we are facing.
20 minutes delay

Lifecare as an investment

Lifecare’s purpose is to develop and license technology for medical use, including facilitating the production and sale of medical devices. Today people with diabetes are dependent on a painful and more than 40-year-old technology. Lifecare’s solutions have the potential to revolutionise the field of continuous glucose measurement for more the more than 450 million people living with diabetes.

 

Top 5 shareholders

Updated September 12, 2022
Name
Holdings
Share
Citizen
Teigland Eiendom AS
20 691 829
20.75 %
NOR
Lacal AS
14 187 712
14.22 %
NOR
VPF Nordea Avkastning
7 980 413
8 %
NOR
Westhawk AS
3 118 462
3.13 %
NOR
Patricia Rodrigues Da Costa Sandquist
2 745 101
2.75 %
NOR
Swipe for more data

Contact

Investor relations